Secondary involvement of ALK− ALCL in the skin has to be distinguished from primary cutaneous CD30+ T-cell lymphoproliferative disorders including lymphomatoid papulosis (LyP), pC-ALCL, and borderline lesions. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.